Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medicare Rx Should Be Model For Covering Uninsured, PhRMA's Holmer Says

This article was originally published in The Pink Sheet Daily

Executive Summary

"Principles" of private sector-driven cost containment can be applied to expanding insurance coverage, PhRMA CEO says. Holmer urges critics of Medicare law to accept that new drug benefit will be created, and focus on ensuring successful implementation.

You may also be interested in...



PhRMA Agenda For 2005 Includes Medicare Start-Up, Liability Reform

Trade association will work on medical malpractice issues particularly at the state level. "Access & Affordability" initiative includes support for expanding coverage to the uninsured, and continued efforts around patient assistance programs.

The Aspirin Test For AI?

US FDA Commissioner Robert Califf tells Congress that regulators don’t have to know how artificial intelligence works in medicine, but must make very sure it actually does work.

Partisan Politics Returns To US FDA Congressional Oversight

The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS058161

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel